SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-051377
Filing Date
2020-11-05
Accepted
2020-11-05 16:32:35
Documents
76
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vtvt-10q_20200930.htm 10-Q 1870657
2 EX-31.1 vtvt-ex311_7.htm EX-31.1 17632
3 EX-31.2 vtvt-ex312_8.htm EX-31.2 17524
4 EX-32.1 vtvt-ex321_9.htm EX-32.1 7266
5 EX-32.2 vtvt-ex322_6.htm EX-32.2 7221
6 GRAPHIC gstaeifrifan000001.jpg GRAPHIC 31579
  Complete submission text file 0001564590-20-051377.txt   6846752

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT vtvt-20200930.xml EX-101.INS 1338265
8 XBRL TAXONOMY EXTENSION SCHEMA vtvt-20200930.xsd EX-101.SCH 63310
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtvt-20200930_cal.xml EX-101.CAL 48662
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtvt-20200930_def.xml EX-101.DEF 245370
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtvt-20200930_lab.xml EX-101.LAB 439187
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtvt-20200930_pre.xml EX-101.PRE 343610
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37524 | Film No.: 201290996
SIC: 2834 Pharmaceutical Preparations